Myocardial dystrophy Catecholamine

Myocardial categolamine dystrophy (MCD) is a pathological condition characterized by disruption of the heart muscle caused by excessive release of catecholamines. Catecholamines are a group of biologically active substances that are produced in the body and are involved in the regulation of many physiological processes.

Normally, catecholamines are released in response to various stress factors, such as physical activity, anxiety, fear, etc. However, with MCD, the level of catecholamines in the blood increases significantly, which leads to disruption of the heart and the development of various cardiovascular complications.

The main symptoms of MCD are rapid heartbeat, shortness of breath, pain in the heart area, weakness, dizziness and others. If left untreated, MCD can lead to arrhythmia, myocardial infarction, and other serious complications.

Various methods are used to diagnose MCD, including electrocardiography, echocardiography, and catecholamine blood tests. Treatment for MCD includes lowering catecholamine levels, normalizing blood pressure, and prescribing medications to improve heart function.

It is important to note that MCD is a fairly rare disease, but its symptoms can be quite serious and life-threatening. Therefore, if any symptoms related to heart function appear, you must consult a doctor for diagnosis and appropriate treatment.



Myocardiomyopathy is a group of genetically determined disorders of the heart muscle, manifested by cardiomyopathy, for which it is not possible to identify an etiological relationship with certain diseases, metabolic disorders, drug exposure or other diseases.

A separate group among myocardiopathies can include idiopathic dilated heart disease (IHD) and other forms of dilated cardiomyopathy (DCM), primarily dilated (non-ischemic) cardiomyopathy, which, as mentioned earlier, is one of the forms of complex multifactorial dystrophic myocardial lesions in as a result of various cardiotoxic effects of exogenous and endogenous substances.